tiprankstipranks
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Advertisement

IN:PHARMABEES ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Buy
17Bullish
5Neutral
0Bearish
Oscillators
Buy
5Bullish
5Neutral
0Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Moving Averages Convergence Divergence (MACD) indicator is 0.36, suggesting Nippon India Nifty Pharma ETF Units Exchange Traded Fund is a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 20-Day exponential moving average is 27.00, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-Day exponential moving average is 26.27, making it a Buy.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Pivot Points

Aug 14, 2026, 01:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
26.35
26.78
27.10
27.53
27.85
28.28
28.60
Fibonacci
26.78
27.06
27.24
27.53
27.81
27.99
28.28

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Moving Averages

Aug 14, 2026, 01:24 AM
Period
Simple
Exponential
MA5
27.36Buy
27.37Buy
MA10
27.31Buy
27.25Buy
MA20
26.97Buy
27.00Buy
MA50
26.14Buy
26.27Buy
MA100
25.00Buy
25.41Buy
MA200
24.05Buy
24.14Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 10-Day exponential moving average is 27.25, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-Day exponential moving average is 25.41, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-day simple moving average is 26.14, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-day simple moving average is 25.00, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 200-day simple moving average is 24.05, creating a Buy signal.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Technical Analysis

Aug 14, 2026, 01:24 AM
Name
Value
Action
RSI (14)
69.08
Neutral
STOCH (9,6)
57.57
Neutral
STOCHRSI (14)
68.25
Neutral
MACD (12,26)
0.36
Buy
ADX (14)
19.39
Buy
Williams %R
-27.51
Buy
CCI (14)
86.82
Neutral
ATR (14)
0.71
-
Ultimate Oscillator
41.55
Neutral
ROC
4.29
Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Relative Strength Index (RSI) is 69.08, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Trend Strength Indicator (ADX) is 19.39, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Commodity Channel Index (CCI) is 86.82, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Price Rate of Change (ROC) is 4.29, creating a Buy signal.

FAQ

Is PHARMABEES a Buy, Hold, or Sell?
Based on PHARMABEES’s technical indicators, PHARMABEES is a Strong Buy.
    What is PHARMABEES’s RSI (14)?
    PHARMABEES’s RSI (14) is 69.08, which suggests PHARMABEES is a Neutral.
      What is PHARMABEES’s MACD?
      PHARMABEES’s MACD is 0.36, which suggests PHARMABEES is a Buy.
        What is PHARMABEES’s 5-day moving average?
        PHARMABEES’s 5-day moving average is 27.36, which suggests PHARMABEES is a Buy.
          What is PHARMABEES’s 20-day moving average?
          PHARMABEES 20-day moving average is 26.97, which suggests PHARMABEES is a Buy.
            What is PHARMABEES’s 50-day moving average?
            PHARMABEES’s 50-day moving average is 26.14, which suggests PHARMABEES is a Buy.
              What is PHARMABEES’s 200-day moving average?
              PHARMABEES’s 200-day moving average is 24.05, which suggests PHARMABEES is a Buy.
                What is PHARMABEES’s Williams % R (14)?
                PHARMABEES’s Williams % R (14) is -27.51, which suggests PHARMABEES is a Buy.
                  What is PHARMABEES’s CCI (14)?
                  PHARMABEES’s CCI (14) is 86.82, which suggests PHARMABEES is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement